Search

James Campbell

James Campbell was appointed Non-Executive Director of Prescient Therapeutics in 2014. Dr Campbell has a demonstrable track record as both a scientist and commercial executive in the sector. He was previously CFO and Chief Operating Officer of Chemgenex which was acquired by Cephalon for 230 million in 2011. At ChemGenex his responsibilities ranged from intellectual property management to licensing and business development. More recently Dr Campbell guided the creation of Invion Limited as an Executive Director and remains a Non-Executive Director of that Company. He has also assisted private biotechnology companies in New Zealand and the US with capital raising and partnering negotiations. Dr Campbell is also a Non-Executive Director of BioProspect Limited and Patrys Limited .
Bio last updated 02 Mar 2019

Article Timeline

Positions - Current

PositionCompanyYearCompany's current rankWA staff
Non-Executive Director
Prescient Therapeutics
Prescient Therapeutics
2014

Positions - Previous

PositionCompanyYearCompany's current rankWA staff
Non-Executive Director
Medibio
Medibio
2014 - 2016
Non-Executive Director
Medibio
Medibio
2014 - 2016

Directors Interests

CompanyDateTransaction typeNumber of sharesPrice per shareTransaction valueNature of change
Prescient Therapeutics23 Nov 2015Issued200,000OtherIssue of options
Source: Morningstar

Roles

2014
Non-Executive Director
Year started and most recent title

Share Transactions

19/11/18
$10k Bought
10/10/18
$1,000 Issued
Total value as at the date of the transaction
Source: Morningstar

BNiQ Disclaimer